Hikma Pharmaceuticals Share Discussion Threads

[scepticalinvestor] 18/5/2022 13:55

And back to the 1600s...

[montyhedge] 18/5/2022 08:23

Barclays have a BUY target 2800p, I go with them.

[scepticalinvestor] 17/5/2022 10:50

I reckon this is being played by short day traders - look at the spikes they set up

[mjneish] 16/5/2022 17:48

Oh yes quite right. I missed that somehow.

[dartboard1] 16/5/2022 16:18

There was an update

[mjneish] 14/5/2022 13:33

Where is this from? I was going from the recent trading statement.

"We continue to expect full year Generics revenue growth in the range 8% to 10% and core operating margin in the range of 24% to 25%, assuming a mid-year launch of sodium oxybate. We expect Generics revenue will be weighted towards the second half of the year."

[dartboard1] 14/5/2022 11:17

Not really. PY generics revenue was 820, and forecast is 710-750. PY generics margin was 24 and forecast is 20. So agree generics is definitely not looking good this year, but there's two other divisions doing well, so group as a while is not in terminal decline as skeptical suggests. Zoom out and have a look at the growth over 5 years (not share price growth of course) and it's a good story

[mjneish] 14/5/2022 10:12

It isn't falling revenue in generics either, just slower growth. And they flagged revenue being weighted towards the end of the year.

[dartboard1] 14/5/2022 08:12

Falling revs in generics this year.. not the other divisions... Or the group overall

[scepticalinvestor] 13/5/2022 13:16

Another 30% drop coming.....

[scepticalinvestor] 13/5/2022 13:10

Huge amounts of stock being dumped. Might be time to cut losses...

[scepticalinvestor] 13/5/2022 08:54

Yes, bargepole territory now...not even a qtr of a billion share buyback helps this

[montyhedge] 12/5/2022 17:44

Lol, you would only lose it on some other share.

[montyhedge] 09/5/2022 09:05

Barclays BUY 2800p target still cheap, if we doubled from here forecast p.e still only around 20.

[blue59] 06/5/2022 15:57

I hope you’re being paid to plug this, and in shares!

[montyhedge] 06/5/2022 15:44

2800p price target for Hikma by Barclays.

[montyhedge] 06/5/2022 15:38

Barclays saying nearly 40% rise potential for Hikma.I reckon that's still to cheap.https://www.directorstalkinterviews.com/hikma-pharmaceuticals-plc-39.3-potential-upside-indicated-by-barclays/4121063347

[blue59] 06/5/2022 08:47

You’re like a scratched 78!

[montyhedge] 06/5/2022 08:30

On the RSI Index Hikma has most oversold, lol, I could have told them that.Still buybacks more shares can be bought.

[blue59] 06/5/2022 07:08

Cliff after cliff!

[volvo] 05/5/2022 17:04

Tread carefully